Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Dose Radiotherapy for Alzheimer's Disease: A Phase I/II Open-Label Feasibility and Safety Study (LDRT-MIND Trial)

NCT07693140 is registered in ClinicalTrials.gov with Evan Thomas as lead sponsor.

NCT NCT07693140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07693140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Dose Radiotherapy for Alzheimer's Disease: A Phase I/II Open-Label Feasibility and Safety Study (LDRT-MIND Trial)
Lead sponsor
Evan Thomas
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 15, 2026
Completion date
May 21, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer, alzheimer dementia, alzheimer dementia (ad), alzheimer s disease, dementia